- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05562583
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support (SAGE-LEAF)
September 30, 2023 updated by: DerShung Yang, PhD, BrightOutcome
The goal of the proposed study, is to adapt a positive emotion intervention for Alzheimer's Disease (AD) caregivers into a self-guided online format that incorporates social connection components and adaptive system feedback mechanisms to promote intervention adherence.
Previous tests of the facilitated version of the program, called SAGE-LEAF (Social Augmentation to self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers), have shown efficacy for improving well-being in dementia caregivers.
If effective, the SAGE-LEAF program can be disseminated to Alzheimer's caregivers nationwide through AD treatment and research centers.
Study Overview
Detailed Description
The prevalence of Alzheimer's Disease (AD) and other dementias is steadily climbing and predicted to affect as many as 16 million Americans by 2050.
In 2016, 59% of dementia caregivers reported experiencing high levels of emotional and physical stress, and the risk that the chronic stress of dementia caregiving places on caregivers for developing a range of physical and mental health issues is extensively documented.
Caregiving-related stress contributes to social isolation, loneliness, and physical illness and increases the risk of caregiver death.
Interventions for dementia caregivers have primarily focused on reducing negative emotions and burden.
However, over the past few decades, it has become clear that positive emotions are uniquely related to better psychological and physical well-being, independent of the effects of negative emotion suggesting that an intervention that specifically targets positive emotion holds promise for improving caregiver well-being and, ultimately, quality of care for the individual living with AD.
The investigators' recent randomized trial of the positive emotion skills intervention, delivered by trained facilitators via the web in N = 170 family caregivers of people with dementia resulted in significant improvements in caregiver psychological well being.
However, facilitator-delivered interventions are costly and difficult to implement with fidelity on a large scale.
Furthermore, a major challenge to advancing behavioral interventions delivered by trained facilitators is assuring fidelity.
The investigators have developed a self-guided online version of the intervention that has shown feasibility and acceptability in several samples, but this version does not capture the critical social connection aspects of the facilitator-delivered intervention.
The investigators propose to take the next step toward closing the science-to-practice gap for the positive emotion regulation intervention by tailoring the self-guided online version specifically for dementia caregivers that incorporates the social connection components to combat the loneliness and isolation experienced by many Alzheimer's caregivers.
The intervention, called SAGE-LEAF (Social Augmentation of self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers), leverages the lessons learned from the original LEAF project and adapts its positive emotion intervention to AD caregivers in a self-guided format while incorporating social connection components and adaptive system feedback mechanisms to promote intervention adherence.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults age 18 and over who identify as the primary caregiver of a family member with Alzheimer's Disease
- Co-reside with the family caregiver
- Speak and read English
- Have internet access and a reliable email address
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention (single arm)
5 session self-guided online delivered positive emotion regulation intervention with social components.
|
SAGE LEAF covers 8 skills and each skill has related home-practice activities that "unlock" every week.
Each week will consist of 1-2 days of didactic material and 5-6 days of real-life home practice.
Participants can access the skills at their own leisure and as often as they'd like within that week.
Participants cannot skip modules with didactic material and can only progress to the next lesson if they have completed the current one.
However, participants can return to old lessons or exercises if they choose to do so at a later time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale
Time Frame: Post-study (week 6)
|
This is to measure the usability of SAGE-LEAF.
Score range: 0-100.
A higher score indicates better usability.
|
Post-study (week 6)
|
|
Percentage of Skill Pages in SAGE-LEAF Accessed by a Participant
Time Frame: Post-study (week 6)
|
This is to measure adherence to SAGE-LEAF intervention.
Score range: 0-100%.
A higher percentage means better adherence to the SAGE-LEAF intervention.
|
Post-study (week 6)
|
|
Willingness to Recommend SAGE-LEAF to Other AD Caregivers
Time Frame: Post-study (week 6)
|
This is to measure the acceptability of SAGE-LEAF.
Score range: 1-10.
A higher score indicates higher acceptability.
|
Post-study (week 6)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Zarit Burden Interview
Time Frame: Pre-study and post-study (week 6)
|
Measuring caregiving burden.
Score range: 0-88.
Higher scores indicate greater burden.
|
Pre-study and post-study (week 6)
|
|
Positive Aspects of Caregiving Scale
Time Frame: Pre-study and post-study (week 6)
|
Measuring positive aspects to caregiving for dementia patients.
Score range: 5-45.
Higher scores indicate better caregivers' outlook on life and self-affirmations.
|
Pre-study and post-study (week 6)
|
|
Positive Affect in Differential Emotions Scale
Time Frame: Pre-study and post-study (week 6)
|
Measuring positive emotions.
Score range: 1-5.
Higher scores indicate higher levels of positive emotions.
|
Pre-study and post-study (week 6)
|
|
Negative Affect in Differential Emotions Scale
Time Frame: Pre-study and post-study (week 6)
|
Measuring positive emotions.
Score range: 1-5.
Higher scores indicate higher levels of negative emotions.
|
Pre-study and post-study (week 6)
|
|
Patient-Reported Outcomes Measurement Information System - Anxiety
Time Frame: Pre-study and post-study (week 6)
|
Measuring anxiety level.
Score range: 20-80.
Higher scores indicate higher anxiety levels.
|
Pre-study and post-study (week 6)
|
|
Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Time Frame: Pre-study and post-study (week 6)
|
Measuring sleep disturbance level.
Score range: 20-80.
Higher scores indicate higher levels of sleep disturbance.
|
Pre-study and post-study (week 6)
|
|
Patient-Reported Outcomes Measurement Information System - Meaning and Purpose
Time Frame: Pre-study and post-study (week 6)
|
Measuring one's sense of life having purpose and that there are good reasons for living.
Score range: 20-80.
Higher scores indicate hopefulness, optimism, goal-directedness, and feelings that one's life is worthy.
|
Pre-study and post-study (week 6)
|
|
Patient-Reported Outcomes Measurement Information System - Social Isolation
Time Frame: Pre-study and post-study (week 6)
|
Measuring perceptions of being avoided, excluded, detached, disconnected from, or unknown by, others.
Score range: 20-80.
Higher scores indicate higher levels of perception of social isolation.
|
Pre-study and post-study (week 6)
|
|
Patient-Reported Outcomes Measurement Information System - Depression
Time Frame: Pre-study and post-study (week 6)
|
Measuring depression level.
Score range: 20-80.
Higher scores indicate higher depression levels.
|
Pre-study and post-study (week 6)
|
|
Oberst Caregiving Burden Scale - Time
Time Frame: Pre-study and post-study (week 6)
|
Measuring caregiving burden in terms of time.
Score range: 1-5.
Higher scores indicate higher levels of caregiver burden.
|
Pre-study and post-study (week 6)
|
|
Oberst Caregiving Burden Scale - Difficulty
Time Frame: Pre-study and post-study (week 6)
|
Measuring caregiving burden in terms of difficulty.
Score range: 1-5.
Higher scores indicate higher levels of caregiver burden.
|
Pre-study and post-study (week 6)
|
|
Role Captivity Sub-scale of Caregiver Reaction Assessment
Time Frame: Pre-study and post-study (week 6)
|
Measuring role captivity in caregiving.
Score 1-4.
Higher scores indicate stronger feelings of role captivity.
|
Pre-study and post-study (week 6)
|
|
Overload Sub-scale of Caregiver Reaction Assessment
Time Frame: Pre-study and post-study (week 6)
|
Measuring the feeling of overload in caregiving.
Score 1-4.
Higher scores indicate stronger feelings of overload.
|
Pre-study and post-study (week 6)
|
|
Caregiving Mastery Subscale of the Caregiving Appraisal Measure
Time Frame: Pre-study and post-study (week 6)
|
Measuring caregiving mastery.
Score range: 1-5.
Higher scores indicate better caregiving mastery.
|
Pre-study and post-study (week 6)
|
|
Cohen's Perceived Stress Scale
Time Frame: Pre-study and post-study (week 6)
|
Measuring perceived stress.
Score range: 0-40.
Higher scores indicate higher levels of perceived stress
|
Pre-study and post-study (week 6)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: DerShung Yang, PhD, BrightOutcome, Inc.
- Principal Investigator: Judith T Moskowitz, PhD, Northwestern University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2019
Primary Completion (Actual)
April 30, 2022
Study Completion (Actual)
April 30, 2022
Study Registration Dates
First Submitted
September 18, 2022
First Submitted That Met QC Criteria
September 29, 2022
First Posted (Actual)
October 3, 2022
Study Record Updates
Last Update Posted (Actual)
October 24, 2023
Last Update Submitted That Met QC Criteria
September 30, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R43AG065080 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.